We are live on ! Find out more
TVRD

Tvardi Therapeutics
TVRD

79 hedge funds and large institutions have $4.56M invested in Tvardi Therapeutics in 2024 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 15 increasing their positions, 24 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.3% less ownership

Funds ownership: 1.2% → 0.9% (-0.3%)

19% less funds holding

Funds holding: 97 → 79 (-18)

38% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 24

53% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 34

79% less capital invested

Capital invested by funds: $21.7M → $4.56M (-$17.1M)

Holders
79
Holders Change
-18
Holders Change %
-18.56%
% of All Funds
1.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
15
Reduced
24
Closed
34
Calls
$16K
Puts
–
Net Calls
+$16K
Net Calls Change
-$26K

Top Buyers

Rank Fund Capital Flow
1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$524K
2
YIH
Y-Intercept (HK)
Hong Kong
+$275K
3
Jane Street
Jane Street
New York
+$249K
4
Goldman Sachs
Goldman Sachs
New York
+$224K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$134K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.77M
2
RA
Rosalind Advisors
Ontario, Canada
-$1.41M
3
State Street
State Street
Massachusetts
-$545K
4
AI
Acuitas Investments
Washington
-$466K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$364K
Name Holding Trade Value Shares
Change 		Change in
Stake
TSS
101
Two Sigma Securities
New York
– -$9.99K -305 Closed
T. Rowe Price Associates
102
T. Rowe Price Associates
Maryland
– -$10K -290 Closed
QT
103
Quantbot Technologies
New York
– -$7.88K -240 Closed
California State Teachers Retirement System (CalSTRS)
104
California State Teachers Retirement System (CalSTRS)
California
– -$4.83K -148 Closed
Legal & General Group
105
Legal & General Group
United Kingdom
– -$3.94K -120 Closed
AIP
106
Ameritas Investment Partners
Nebraska
– -$3.01K -92 Closed
AB
107
Amalgamated Bank
New York
– -$1K -42 Closed
Simplex Trading
108
Simplex Trading
Illinois
– -$620 -26 -20%
FFA
109
Farther Finance Advisors
California
– -$596 -25 Closed
FIM
110
Fernwood Investment Management
Massachusetts
– -$577 -18 Closed
Carson Wealth (CWM LLC)
111
Carson Wealth (CWM LLC)
Nebraska
– -$239 -10 -27%
CA
112
Clearstead Advisors
Ohio
– -$151 -6 Closed
TC
113
Truvestments Capital
Florida
– -$160 -5 Closed
CFM
114
Catalyst Funds Management
Australia
– -$46 -1 Closed
AWM
115
Avior Wealth Management
Nebraska
– -$9 – –
CA
116
CoreCap Advisors
Michigan
– -$15 – –
1 2 3 4
5

TVRD Hedge Fund Activity: Q2 2024 in Review

79 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Tvardi Therapeutics (TVRD) for Q2 2024, worth a combined $4.56M — down 79% from $21.7M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of TVRD and 16 opened new positions — a net loss of 18 holders — while 24 trimmed existing stakes and 15 added.

The largest buyer was BNP Paribas Financial Markets, adding an estimated $524K. The largest seller was BlackRock, cutting an estimated $1.77M.

  • 79 institutional investors held Tvardi Therapeutics (TVRD) as of Q2 2024, down from 97 in Q1 2024.
  • Funds reported $4.56M of Tvardi Therapeutics stock for Q2 2024, down 79% quarter-over-quarter.
  • 16 funds opened new Tvardi Therapeutics positions in Q2 2024 and 34 closed out, a net change of -18 holders.
  • The largest Tvardi Therapeutics buyer in Q2 2024 was BNP Paribas Financial Markets, an estimated $524K added.
  • The largest Tvardi Therapeutics seller in Q2 2024 was BlackRock, an estimated $1.77M sold.

Based on aggregated 13F filings for Q2 2024.